Brian Naber says growing up in a farming family in southwest Minnesota helped prepare him for the rigors of leading the ...
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of ...
Elliott Management held talks with private equity groups in recent months to gauge interest in buying Bayer’s (BAYRY) consumer health business, ...
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...
Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court ...
Bayer (BAYRY) stock fell after the German company was ordered by a Georgia jury to pay $2.1 billion to a plaintiff who claimed his cancer was ...
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's ...
FRANKFURT (Reuters) -Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results